InflaRx (IFRX) Research & Development (2016 - 2026)
InflaRx (IFRX) recorded Research & Development of -$5.51 million in Q2 2026, compared with -$8.15 million a year earlier.
Powered by 
Analysis
InflaRx (IFRX) Research & Development (2016 - 2026) Analysis & Trends
On a TTM basis, InflaRx's Research & Development came in at -$29.94 trillion as of Jun 30, 2026; for FY2025, it was -$29.06 trillion.
- Across earlier years, Research & Development came in at -$37.79 trillion in FY2024, -$44.14 trillion in FY2023, -$38.29 trillion in FY2022 and -$40.84 trillion in FY2021.
- Quarterly Research & Development has ranged from -$29.94 trillion in Q4 2025 to -$4.88 million in Q1 2026 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$4.88 million (Q1 2026), -$29.94 trillion (Q4 2025) and -$7.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,135.43 Bn | 1,104.02 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 616.54 Bn | 535.06 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.55 Bn | 474.66 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 367.19 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.91 Bn | 261.90 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.40 Bn | 235.09 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.18 Bn | 191.58 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 190.55 Bn | 164.75 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.40 Bn | 116.05 Bn | 10.94 Bn | 2.81 Bn |
| 10 | InflaRx | 105.31 Mn | -228.31 Mn | 2.74 Mn | -5.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.51 Mn |
| Mar 31, 2026 | -4.88 Mn |
| Dec 31, 2025 | 53.76 Mn |
| Sep 30, 2025 | -7.30 Mn |
| Jun 30, 2025 | -8.15 Mn |
| Mar 31, 2025 | -7.38 Mn |
| Dec 31, 2024 | 68.20 Mn |
| Sep 30, 2024 | -12.23 Mn |
| Jun 30, 2024 | -10.79 Mn |
| Mar 31, 2024 | -7.93 Mn |
| Dec 31, 2023 | 79.60 Mn |
| Sep 30, 2023 | -7.95 Mn |
| Jun 30, 2023 | -11.89 Mn |
| Mar 31, 2023 | -15.81 Mn |
| Dec 31, 2022 | 68.07 Mn |
| Sep 30, 2022 | -7.60 Mn |
| Jun 30, 2022 | 11.93 Mn |
| Mar 31, 2022 | -11.75 Mn |
| Dec 31, 2021 | 70.08 Mn |
| Sep 30, 2021 | -11.04 Mn |
API Access
InflaRx Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();